The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis
Open accessAbstract
Central serous chorioretinopathy (CSCR) is a major cause of vision threat among middle-aged male individuals. Multimodal imaging led to the description of a wide range of CSCR manifestations, and highlighted the contribution of the choroid and pigment epithelium in CSCR pathogenesis. However, the exact molecular mechanisms of CSCR have remained uncertain. The aim of this review is to recapitulate the clinical understanding of CSCR, with an emphasis on the most recent findings on epidemiology, risk factors, clinical and imaging diagnosis, and treatments options. It also gives an overview of the novel mineralocorticoid pathway hypothesis, from animal data to clinical evidences of the biological efficacy of oral mineralocorticoid antagonists in acute and chronic CSCR patients. In rodents, activation of the mineralocorticoid pathway in ocular cells either by intravitreous injection of its specific ligand, aldosterone, or by over-expression of the receptor specifically in the vascular endothelium, induced ocular phenotypes carrying many features of acute CSCR. Molecular mechanisms include expression of the calcium-dependent potassium channel (KCa2.3) in the endothelium of choroidal vessels, inducing subsequent vasodilation. Inappropriate or over-activation of the mineralocorticoid receptor in ocular cells and other tissues (such as brain, vessels) could link CSCR with the known co-morbidities observed in CSCR patients, including hypertension, coronary disease and psychological stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
A Pilot Study of Enhanced Depth Imaging Optical Coherence Tomography of the Choroid in Normal Eyes
Margolis, R., & Spaide, R. F. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2008.12.008 · Cited by 1,344
IMAMURA, Y., FUJIWARA, T., MARGOLIS, R., & SPAIDE, R. F. (2009) · Retina · doi:10.1097/iae.0b013e3181be0a83 · Cited by 955
Delori, F. C., Dorey, C. K., Staurenghi, G., Arend, O., Goger, D. G., & Weiter, J. J. (1995) · PubMed · Cited by 948
Enhanced Depth Imaging Optical Coherence Tomography of the Choroid in Highly Myopic Eyes
Fujiwara, T., Imamura, Y., Margolis, R., Slakter, J. S., & Spaide, R. F. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.04.029 · Cited by 823
Fluorescence Properties and Metabolic Features of Indocyanine Green (ICG) as Related to Angiography
Desmettre, T., Devoisselle, J. M., & Mordon, S. (2000) · Survey of Ophthalmology · doi:10.1016/s0039-6257(00)00123-5 · Cited by 754
Central serous chorioretinopathy
Wang, M., Munch, I. C., Hasler, P. W., Prünte, C., & Larsen, M. (2008) · Acta Ophthalmologica · doi:10.1111/j.1600-0420.2007.00889.x · Cited by 726
Central Serous Chorioretinopathy: Update on Pathophysiology and Treatment
Nicholson, B., Noble, J., Forooghian, F., & Meyerle, C. (2013) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2012.07.004 · Cited by 649
Subfoveal Choroidal Thickness: The Beijing Eye Study
Wei, W. B., Xu, L., Jonas, J. B., Shao, L., Du, K. F., Wang, S., Chen, C. X., Xu, J., Wang, Y. X., Zhou, J. Q., et al. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2012.07.048 · Cited by 599
Central Serous Chorioretinopathy in Younger and Older Adults
Spaide, R. F., Campeas, L., Haas, A., Yannuzzi, L. A., Fisher, Y. L., Guyer, D. R., Slakter, J. S., Sorenson, J. A., & Orlock, D. A. (1996) · Ophthalmology · doi:10.1016/s0161-6420(96)30386-2 · Cited by 551
TYPE-A BEHAVIOR AND CENTRAL SEROUS CHORIORETINOPATHY
YANNUZZI, L. A. (1987) · Retina · doi:10.1097/00006982-198700720-00009 · Cited by 504
Reynolds, R. M. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.08.012 · Cited by 497
Optical coherence tomography: Imaging of the choroid and beyond
Mrejen, S., & Spaide, R. F. (2013) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2012.12.001 · Cited by 477
Risk factors for central serous chorioretinopathy
Haimovici, R., Koh, S., Gagnon, D. R., Lehrfeld, T., & Wellik, S. (2004) · Ophthalmology · doi:10.1016/j.ophtha.2003.09.024 · Cited by 475
The Incidence of Central Serous Chorioretinopathy in Olmsted County, Minnesota, 1980–2002
Kitzmann, A. S., Pulido, J. S., Diehl, N. N., Hodge, D. O., & Burke, J. P. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.02.032 · Cited by 466
Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis
Brown, N. J. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.110 · Cited by 451
Near-Infrared Autofluorescence Imaging of the Fundus: Visualization of Ocular Melanin
Keilhauer, C. N., & Delori, F. C. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0122 · Cited by 397
Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy
Zhao, M., Célérier, I., Bousquet, E., Jeanny, J.-C., Jonet, L., Savoldelli, M., Offret, O., Curan, A., Farman, N., Jaisser, F., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61427 · Cited by 383
Self-citationSystemic findings associated with central serous chorioretinopathy
Tittl, M. K., Spaide, R. F., Wong, D., Pilotto, E., Yannuzzi, L. A., Fisher, Y. L., Freund, B., Guyer, D. R., Slakter, J. S., & Sorenson, J. A. (1999) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(99)00075-6 · Cited by 382
SUBFOVEAL CHOROIDAL THICKNESS IN FELLOW EYES OF PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY
Maruko, I., Iida, T., Sugano, Y., Ojima, A., & Sekiryu, T. (2011) · Retina · doi:10.1097/iae.0b013e31820f4b39 · Cited by 319
The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy
Piccolino, F. C., de la Longrais, R. R., Ravera, G., Eandi, C. M., Ventre, L., Abdollahi, A. A., & Manea, M. (2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2004.08.037 · Cited by 315
Central Serous Chorioretinopathy and Glucocorticoids
Bouzas, E. A., Karadimas, P., & Pournaras, C. J. (2002) · Survey of Ophthalmology · doi:10.1016/s0039-6257(02)00338-7 · Cited by 315
Koizumi, H., Yamagishi, T., Yamazaki, T., Kawasaki, R., & Kinoshita, S. (2011) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-011-1620-1 · Cited by 315
Kim, S.-W., Oh, J., Kwon, S.-S., Yoo, J., & Huh, K. (2011) · Retina · doi:10.1097/iae.0b013e31821801c5 · Cited by 312
Subfoveal Choroidal Thickness in Relation to Sex and Axial Length in 93 Danish University Students
Li, X. Q., Larsen, M., & Munch, I. C. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-8108 · Cited by 312
PERSISTENT AND BILATERAL CHOROIDAL VASCULAR ABNORMALITIES IN CENTRAL SEROUS CHORIORETINOPATHY
IIDA, T., KISHI, S., HAGIMURA, N., & SHIMIZU, K. (1999) · Retina · doi:10.1097/00006982-199911000-00005 · Cited by 310
Schlötzer-Schrehardt, U., Viestenz, A., Naumann, G. O., Laqua, H., Michels, S., & Schmidt-Erfurth, U. (2002) · Graefe’s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-002-0517-4 · Cited by 278
Central serous chorioretinopathy and glucocorticoids
Cusani, M. (2004) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2003.10.002 · Cited by 273
Yannuzzi, L. A., Shakin, J. L., Fisher, Y. L., & Altomonte, M. A. (1984) · Ophthalmology · doi:10.1016/s0161-6420(84)34117-3 · Cited by 269
POLYPOIDAL CHOROIDAL VASCULOPATHY: Evidence-Based Guidelines for Clinical Diagnosis and Treatment
Koh, A. H. C., Chen, L.-J., Chen, S.-J., Chen, Y., Giridhar, A., Iida, T., Kim, H., Lai, T. Y. Y., Lee, W. K., Li, X., et al. (2013) · Retina · doi:10.1097/iae.0b013e3182852446 · Cited by 265
Fung, A. T., Yannuzzi, L. A., & Freund, K. (2012) · Retina · doi:10.1097/iae.0b013e3182680a66 · Cited by 250
Central Serous Chorioretinopathy in Endogenous Hypercortisolism
Bouzas, E. A. (1993) · Archives of Ophthalmology · doi:10.1001/archopht.1993.01090090081024 · Cited by 243
Central Serous Chorioretinopathy: A Personal Perspective
Yannuzzi, L. A. (2010) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.11.017 · Cited by 238
Indocyanine Green Angiography: A Perspective on Use in the Clinical Setting
Yannuzzi, L. A. (2011) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2011.01.043 · Cited by 235
Fundus Autofluorescence and Central Serous Chorioretinopathy
SPAIDE, R., & KLANCNIKJR, J. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2005.01.003 · Cited by 226
CYSTOID MACULAR DEGENERATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
IIDA, T., YANNUZZI, L. A., SPAIDE, R. F., BORODOKER, N., CARVALHO, C. A., & NEGRÃO, S. (2003) · RETINA · doi:10.1097/00006982-200302000-00001 · Cited by 215
Bousquet, E., Beydoun, T., Zhao, M., Hassan, L., Offret, O., & Behar-Cohen, F. (2013) · Retina · doi:10.1097/iae.0b013e318297a07a · Cited by 212
Self-citationFeatures of abnormal choroidal circulation in central serous chorioretinopathy
Kitaya, N. (2003) · British Journal of Ophthalmology · doi:10.1136/bjo.87.6.709 · Cited by 204
Endogenous cortisol profile in patients with central serous chorioretinopathy
Garg, S. P., Dada, T., Talwar, D., & Biswas, N. R. (1997) · British Journal of Ophthalmology · doi:10.1136/bjo.81.11.962 · Cited by 202
Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy
Yannuzzi, L. A., Freund, K. B., Goldbaum, M., Scassellati-Sforzolini, B., Guyer, D. R., Spaide, R. F., Maberley, D., Wong, D. W. K., Slakter, J. S., Sorenson, J. A., et al. (2000) · Ophthalmology · doi:10.1016/s0161-6420(99)00173-6 · Cited by 197
Ferrara, D., Mohler, K. J., Waheed, N., Adhi, M., Liu, J. J., Grulkowski, I., Kraus, M. F., Baumal, C., Hornegger, J., Fujimoto, J. G., et al. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.10.014 · Cited by 189
The brain mineralocorticoid receptor and stress resilience
ter Heegde, F., De Rijk, R. H., & Vinkers, C. H. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.10.022 · Cited by 187
Optical Coherence Tomography–Assisted Enhanced Depth Imaging of Central Serous Chorioretinopathy
Yang, L., Jonas, J. B., & Wei, W. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-10991 · Cited by 186
Gass, J. D. M., & Little, H. (1995) · Ophthalmology · doi:10.1016/s0161-6420(95)30960-8 · Cited by 186
Polypoidal Choroidal Vasculopathy with Choroidal Vascular Hyperpermeability
Sasahara, M., Tsujikawa, A., Musashi, K., Gotoh, N., Otani, A., Mandai, M., & Yoshimura, N. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.05.051 · Cited by 182
Matsumoto, H., Sato, T., & Kishi, S. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.01.018 · Cited by 182
MULTIMODAL IMAGING OF PIGMENT EPITHELIAL DETACHMENT: A Guide to Evaluation
Mrejen, S., sarraf, D., mukkamala, S. K., & freund, K. B. (2013) · Retina · doi:10.1097/iae.0b013e3182993f66 · Cited by 178
Mineralocorticoid receptors in vascular function and disease
McCurley, A., & Jaffe, I. Z. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.06.014 · Cited by 178
Jirarattanasopa, P., Ooto, S., Nakata, I., Tsujikawa, A., Yamashiro, K., Oishi, A., & Yoshimura, N. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-9619 · Cited by 175
Vascular Actions of Aldosterone
Briet, M., & Schiffrin, E. L. (2013) · Journal of Vascular Research · doi:10.1159/000345243 · Cited by 174
Wilkinson-Berka, J. L., Tan, G., Jaworski, K., Harbig, J., & Miller, A. G. (2009) · Circulation Research · doi:10.1161/circresaha.108.176008 · Cited by 172
Chan, W.-M., Lai, T. Y. Y., Liu, D. T. L., & Lam, D. S. C. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.02.039 · Cited by 167
Glucocorticoids and endothelial cell barrier function
Salvador, E., Shityakov, S., & Förster, C. Y. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1762-z · Cited by 166
Zhao, M., Valamanesh, F., Celerier, I., Savoldelli, M., Jonet, L., Jeanny, J., Jaisser, F., Farman, N., & Behar‐Cohen, F. (2010) · The FASEB Journal · doi:10.1096/fj.09-154344 · Cited by 166
Self-citationCentral Serous Chorioretinopathy Associated with Inhaled or Intranasal Corticosteroids
Haimovici, R., Gragoudas, E. S., Duker, J. S., Sjaarda, R. N., & Eliott, D. (1997) · Ophthalmology · doi:10.1016/s0161-6420(97)30082-7 · Cited by 164
Epigenetic effects of stress and corticosteroids in the brain
Hunter, R. G. (2012) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2012.00018 · Cited by 163
Mannheim Classification of Nongenomically Initiated (Rapid) Steroid Action(s)
Falkenstein, E., Norman, A. W., & Wehling, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.5.2072 · Cited by 162
The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure
Cat, A. N. D., Griol‐Charhbili, V., Loufrani, L., Labat, C., Benjamin, L., Farman, N., Lacolley, P., Henrion, D., & Jaisser, F. (2010) · The FASEB Journal · doi:10.1096/fj.09-147926 · Cited by 161
Self-citationElongation of Photoreceptor Outer Segment in Central Serous Chorioretinopathy
Matsumoto, H., Kishi, S., Otani, T., & Sato, T. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.08.024 · Cited by 158
Tsai, D., Chen, S. J., Huang, C.-C., Chou, P., Chung, C.-M., Huang, P. H., Lin, S. J., Chen, J.-W., Chen, T.-J., Leu, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066858 · Cited by 157
Ojima, Y., Hangai, M., Sasahara, M., Gotoh, N., Inoue, R., Yasuno, Y., Makita, S., Yatagai, T., Tsujikawa, A., & Yoshimura, N. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.02.015 · Cited by 146
de Jong, E. K., Breukink, M. B., Schellevis, R. L., Bakker, B., Mohr, J. K., Fauser, S., KEUNEN, J. E. E., Hoyng, C. B., den Hollander, A. I., & Boon, C. J. F. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.09.026 · Cited by 141
Intravitreal Steroids for the Treatment of Retinal Diseases
Sarao, V., Veritti, D., Boscia, F., et al. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/989501 · Cited by 140
Funder, J. W. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.12.010 · Cited by 137
Pregnancy-associated Retinal Diseases and Their Management
Errera, M., Kohly, R. P., & da Cruz, L. (2013) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2012.08.001 · Cited by 137
Transient MEK inhibitor-associated retinopathy in metastatic melanoma
Urner-Bloch, U., Urner, M., Stieger, P., Galliker, N., Winterton, N., Zubel, A., Parseval, L. M., Dummer, R., & Goldinger, S. M. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu169 · Cited by 135
SPIRONOLACTONE FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY
Bousquet, E., Beydoun, T., Rothschild, P.-R., Bergin, C., Zhao, M., Batista, R., Brandely, M.-L., Couraud, B., Farman, N., Gaudric, A., et al. (2015) · Retina · doi:10.1097/iae.0000000000000614 · Cited by 135
Self-citationSpironolactone Metabolism: Steady‐State Serum Levels of the Sulfur‐Containing Metabolites
Gardiner, P., Schrode, K. B., Quinlan, D., Martin, B. K., Boreham, D. R., Rogers, M. S., Stubbs, K., Smith, M. E., & Karim, A. (1989) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1989.tb03339.x · Cited by 133
Tewari, H. K., Gadia, R., Kumar, D., Venkatesh, P., & Garg, S. P. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-1246 · Cited by 132
Miki, A., Kondo, N., Yanagisawa, S., Bessho, H., Honda, S., & Negi, A. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.11.020 · Cited by 128
Diffuse retinal pigment epitheliopathy complicating systemic corticosteroid treatment.
Polak, B. C. P., Baarsma, G. S., & SNYERS, B. (1995) · British Journal of Ophthalmology · doi:10.1136/bjo.79.10.922 · Cited by 127
Qualitative and quantitative assessment of the circadian rhythm of cortisol in pregnancy
Cousins, L., Rigg, L. A., Hollingsworth, D. R., Meis, P. J., Franz Halberg, A., Brink, G. W., & Yen, S. S. C. (1983) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(83)90309-5 · Cited by 125
Wu, Z. H. Y., Lai, R. Y. K., Yip, Y. W. Y., Chan, W. M., Lam, D. S. C., & Lai, T. Y. Y. (2011) · Retina · doi:10.1097/ftd.0b013e31820beb02 · Cited by 124
Central Serous Chorioretinopathy in Women
Quillen, D. A., Gass, J. D. M., Brod, R. D., Gardner, T. W., Blankenship, G. W., & Gottlieb, J. L. (1996) · Ophthalmology · doi:10.1016/s0161-6420(96)30730-6 · Cited by 123
Abnormalities of fundus autofluorescence in central serous retinopathy
von Rückmann, A., Fitzke, F. W., Fan, J., Halfyard, A. S., & Bird, A. C. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01428-9 · Cited by 122
McGraw, A. P., Bagley, J., Chen, W., Galayda, C., Nickerson, H., Armani, A., Caprio, M., Carmeliet, P., & Jaffe, I. Z. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.112.000018 · Cited by 118
Mechanisms of ligand specificity of the mineralocorticoid receptor
Fuller, P. J., Yao, Y., Yang, J., & Young, M. J. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0372 · Cited by 116
Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine
Funder, J. W. (2013) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s13783 · Cited by 115
Increased Vasoconstrictor Sensitivity to Glucocorticoids in Essential Hypertension
Walker, B. R., Best, R., Shackleton, C. H. L., Padfield, P. L., & Edwards, C. R. W. (1996) · Hypertension · doi:10.1161/01.hyp.27.2.190 · Cited by 115
Extrarenal effects of aldosterone
Cat, A. N. D., & Jaisser, F. (2012) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32834fb25b · Cited by 115
Self-citationEstrogen Receptor Inhibits Mineralocorticoid Receptor Transcriptional Regulatory Function
Mueller, K. B., Lu, Q. R., Mohammad, N. N., Luu, V., McCurley, A., Williams, G. H., Adler, G. K., Karas, R. H., & Jaffe, I. Z. (2014) · Endocrinology · doi:10.1210/en.2014-1270 · Cited by 108
Evaluation of central serous retinopathy with en face optical coherence tomography
van Velthoven, M. E. J. (2005) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.073056 · Cited by 107
PHARMACOKINETICS AND METABOLISM OF [14C]EPLERENONE AFTER ORAL ADMINISTRATION TO HUMANS
Cook, C. S., Berry, L., Bible, R. H., Hribar, J. D., Hajdu, E., & Liu, N. W. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.11.1448 · Cited by 107
Cadherin 5 is Regulated by Corticosteroids and Associated with Central Serous Chorioretinopathy
Schubert, C., Pryds, A., Zeng, S., Xie, Y., Freund, K. B., Spaide, R. F., Merriam, J. C., BARBAZETTO, I. A., Slakter, J. S., Chang, S., et al. (2014) · Human Mutation · doi:10.1002/humu.22551 · Cited by 105
Tittl, M., Maár, N., Polska, E., Weigert, G. ̈., Stur, M., & Schmetterer, L. F. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0268 · Cited by 102
Tsujikawa, A., Ojima, Y., Yamashiro, K., Ooto, S., Tamura, H., Nakagawa, S., & Yoshimura, N. (2010) · Retina · doi:10.1097/iae.0b013e3181c72068 · Cited by 101
Chung, Y.-R., Seo, E. J., Lew, H. M., & Lee, K. (2013) · Eye · doi:10.1038/eye.2013.236 · Cited by 100
Bae, S. H., Heo, J. W., Kim, C., Kim, T. W., Lee, J. Y., Song, S. J., Park, T. K., Moon, S. W., & Chung, H. (2011) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2011.04.008 · Cited by 96
McCannel, T. A., Chmielowski, B., Finn, R. S., Goldman, J., Ribas, A., Wainberg, Z. A., & McCannel, C. A. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2014.976 · Cited by 90
Systemic Factors Associated with Central Serous Chorioretinopathy in Koreans
Eom, Y., Oh, J., Kim, S., & Huh, K. (2012) · Korean Journal of Ophthalmology · doi:10.3341/kjo.2012.26.4.260 · Cited by 83
Zhao, M., Bousquet, E., Valamanesh, F., Farman, N., Jeanny, J., Jaisser, F., & Béhar‐Cohen, F. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7675 · Cited by 82
Self-citationObstructive sleep apnea in patients with central serous chorioretinopathy
Kloos, P., Laube, I., & Thölen, A. M. (2008) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-008-0837-0 · Cited by 79
Togni, S., & Mazzolani, F. (2013) · Clinical ophthalmology · doi:10.2147/opth.s45820 · Cited by 77
Chan, W., Lam, D. S. C., Lai, T. Y. Y., Yuen, K. S. C., Liu, D. T. L., Chan, C. K. M., & Chen, W.-Q. (2003) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(03)00462-8 · Cited by 76
Nuclear receptors in inflammation control: Repression by GR and beyond
Chinenov, Y. V., Gupte, R., & Rogatsky, I. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.04.006 · Cited by 75
Juruena, M. F., Baes, C. V. W., Menezes, I. C., & Graeff, F. G. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150105125500 · Cited by 75
Corticosteroid-induced central serous chorioretinopathy
Wakakura, M. (1997) · Japanese Journal of Ophthalmology · doi:10.1016/s0021-5155(97)00027-0 · Cited by 73
Conrad, R., Geiser, F., Kleiman, A., Zur, B., & Godt, A. K. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/631687 · Cited by 72
Matsumoto, H., Kishi, S., Sato, T., & Mukai, R. (2011) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2010.09.031 · Cited by 71
Pitcher, J. D., Witkin, A. J., DeCroos, F. C., & Ho, A. C. (2015) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2014-306018 · Cited by 71
Central Serous Chonoretinopathy Occurring in Patients 60 Years of Age and Older
Schatz, H., Madeira, D., Johnson, R. N., & McDonald, H. R. (1992) · Ophthalmology · doi:10.1016/s0161-6420(92)32010-x · Cited by 69
Central serous chorioretinopathy after epidural corticosteroid injection
Iida, T., Spaide, R. F., Negrão, S., CARVALHO, C., & Yannuzzi, L. A. (2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)00970-9 · Cited by 65
Mineralocorticoid receptors in the heart: lessons from cell-selective transgenic animals
Young, M. J., & Rickard, A. J. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0471 · Cited by 65
CONCENTRATION OF CYTOKINES IN THE AQUEOUS HUMOR OF PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY
Shin, M. C., & Lim, J. W. (2011) · Retina · doi:10.1097/iae.0b013e31820a6a17 · Cited by 63
Hamzah, F., Shinojima, A., Mori, R., & Yuzawa, M. (2014) · BMC Ophthalmology · doi:10.1186/1471-2415-14-145 · Cited by 62
Rishi, P., Rishi, E., Mathur, G., & Raval, V. R. (2013) · Eye · doi:10.1038/eye.2013.106 · Cited by 61
Clinical characteristics of central serous chorioretinopathy in women
Perkins, S. L., Kim, J. E., Pollack, J. S., & Merrill, P. T. (2002) · Ophthalmology · doi:10.1016/s0161-6420(01)00951-4 · Cited by 58
Alexithymia and Emotional Distress in Patients With Central Serous Chorioretinopathy
Conrad, R., Weber, N., Lehnert, M., Holz, F. G., Liedtke, R., & Eter, N. (2007) · Psychosomatics · doi:10.1176/appi.psy.48.6.489 · Cited by 57
OBSTRUCTIVE SLEEP APNEA AND CENTRAL SEROUS CHORIORETINOPATHY
Brodie, F. L., Charlson, E. S., Alemán, T. S., Salvo, R., Gewaily, D. Y., Lau, M. K., Farren, N. D., Engelhard, S. B., Pistilli, M., & Brucker, A. J. (2014) · Retina · doi:10.1097/iae.0000000000000326 · Cited by 57
The mineralocorticoid receptor as a novel player in skin biology: beyond the renal horizon?
Farman, N., Maubec, E., Pöeggeler, B., Klatte, J. E., Jaisser, F., & Paus, R. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.01011.x · Cited by 56
Self-citationHan, J. M., Hwang, J., Kim, J. S., Park, K. H., & Woo, S. J. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12854 · Cited by 56
The multifaceted mineralocorticoid receptor
Gomez‐Sanchez, E., & Gomez‐Sanchez, C. E. (2014) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2014.tb00569.x · Cited by 55
Spironolactone in the treatment of central serous chorioretinopathy – a case series
Herold, T., Prause, K., Wolf, A., Mayer, W. J., & ULBIG, M. W. (2014) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-014-2780-6 · Cited by 55
Infrared Fundus Autofluorescence and Central Serous Chorioretinopathy
Sekiryu, T., Iida, T., Maruko, I., Saito, K., & Kondo, T. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-5009 · Cited by 54
Iacono, P., Parodi, M. B., Papayannis, A., Spina, C. L., Varano, M., & Bandello, F. M. (2015) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-014-2899-5 · Cited by 54
Mineralocorticoid receptors: Emerging complexity and functional diversity
Odermatt, A., & Atanasov, A. G. (2008) · Steroids · doi:10.1016/j.steroids.2008.10.010 · Cited by 50
Role of Mineralocorticoid Receptor on Experimental Cerebral Aneurysms in Rats
Tada, Y., Kitazato, K. T., Tamura, T., Yagi, K., Shimada, K., Kinouchi, T., Satomi, J., & Nagahiro, S. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.134130 · Cited by 50
Teke, M. Y., Elgin, U., Nalcacioglu-Yüksekkaya, P., Şen, E. M., Ozdal, P. C., & Öztürk, F. (2014) · Europe PMC (PubMed Central) · doi:10.3980/j.issn.2222-3959.2014.02.29 · Cited by 45
Dang, Y., Mu, Y., Zhao, M., et al. (2013) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s50407 · Cited by 45
Self-citationChen, S.-N., Chen, Y.-C., & Lian, I. (2013) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2013-303945 · Cited by 45
Vascular effects of aldosterone: Sorting out the receptors and the ligands
Feldman, R. D., & Gros, R. (2013) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12157 · Cited by 43
Central serous chorioretinopathy and risk of ischaemic stroke: a population-based cohort study
Tsai, D., Huang, C., Chen, S., Chou, P., Chung, C., Chan, W., Huang, P., Chen, T.-J., Lin, S., Chen, J., et al. (2012) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2012-301810 · Cited by 42
Nitric Oxide-mediated Dilation of Arterioles to Intraluminal Administration of Aldosterone
Heylen, E., Huang, A., Sun, D., & Kaley, G. (2009) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181bfb00d · Cited by 41
Kim, J. H., Kang, S. W., Kim, J., & Kim, S. J. (2013) · Eye · doi:10.1038/eye.2013.78 · Cited by 40
Central Serous Chorioretinopathy After Epidural Steroid Injection
Pizzimenti, J. J., & Daniel, K. P. (2005) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.2005.25.8.1141 · Cited by 38
Ghanem, C. I., Gómez, P. C., Arana, M. C., Perassolo, M., Carpini, G. D., Luquita, M. G., Veggi, L. M., Catania, V. A., Bengochea, L. A., & Mottino, A. D. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.105668 · Cited by 31
The mineralocorticoid receptor in rodent retina: ontogeny and molecular identity.
Golestaneh, N., Picaud, S. A., & Mirshahi, M. (2002) · PubMed · Cited by 31
Sarkar, K., Mondal, L. K., Datta, H., & Pr, C. (2005) · Indian Journal of Ophthalmology · doi:10.4103/0301-4738.16181 · Cited by 29
Cardiac effects of aldosterone: Does gender matter?
Mihailidou, A. S., & Ashton, A. W. (2014) · Steroids · doi:10.1016/j.steroids.2014.08.013 · Cited by 28
Tsai, D., Huang, C., Chen, S., Chou, P., Chung, C., Chan, W., Huang, P., Lin, S., Chen, J., & Leu, H. (2012) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2012.02528.x · Cited by 18
CENTRAL SEROUS CHORIORETINOPATHY ASSOCIATED WITH THE USE OF EPHEDRA
Pierce, K. K., & Lane, R. G. (2009) · Retinal Cases & Brief Reports · doi:10.1097/icb.0b013e31818ad3ce · Cited by 16
Central serous chorioretinopathy and idiopathic nonhistaminergic angioedema
Edalati, K., Roesch, M. T., Buchanan, M. L., Teeter, M. M., & Maberley, D. (2009) · Canadian Journal of Ophthalmology · doi:10.3129/i09-105 · Cited by 7
Cited by
Mechanisms of macular edema: Beyond the surface
Daruich, A., Matet, A., Moulin, A., Kowalczuk, L., Nicolas, M., Sellam, A., Rothschild, P.-R., Omri, S., Gélizé, E., Jonet, L., et al. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.10.006 · Cited by 708
Self-citationCentral serous chorioretinopathy: Towards an evidence-based treatment guideline
van Rijssen, T. J., van Dijk, E. H. C., Yzer, S., Ohno-Matsui, K., Keunen, J. E. E., Schlingemann, R. O., Sivaprasad, S., Querques, G., Downes, S. M., Fauser, S., et al. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.07.003 · Cited by 478
van Dijk, E. H. C., Fauser, S., Breukink, M. B., Blanco-Garavito, R., Groenewoud, J. M. M., Keunen, J. E. E., Peters, P. J. H., Dijkman, G., Souied, E. H., MacLaren, R. E., et al. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2018.04.021 · Cited by 351
Jaisser, F., & Farman, N. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011106 · Cited by 327
Self-citationLaíns, I., Wang, J. C., Cui, Y., Katz, R., Vingopoulos, F., Staurenghi, G., Vavvas, D. G., Miller, J. W., & Miller, J. B. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100951 · Cited by 324
Metadata
- Authors
- Daruich, A., Matet, A., Dirani, A., Bousquet, E., Zhao, M., Farman, N., Jaisser, F., & Behar-Cohen, F.
- Venue
- Progress in Retinal and Eye Research
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 48
- Pages
- 82-118
- ISSN
- 1350-9462 (ISSN-L)
- OpenAlex
- W417772227
- Cited by
- 989
- References
- 133
- FWCI
- 57.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.